Aprecia Pharmaceuticals is a pharmaceutical company that develops and manufactures 3D printed drugs. The company's proprietary ZipDose Technology platform enables the production of rapidly disintegrating formulations of high-dose medications. Aprecia's first product, SPRITAM, is the first and only FDA-approved 3D printed prescription drug for the treatment of epilepsy. The company was founded in 2003 and is headquartered in Berwyn, Pennsylvania.